A new machine-learning tool used by Citadel and Balyasny to rank their brokers hopes to put an end to the 'old boys network'

The shrinking commissions that banks have made of their equity broker units may grow even smaller.

April 19, 2019   |   View Online »

A new machine-learning tool used by Citadel and Balyasny to rank their brokers hopes to put an end to the 'old boys network' Bradley Saacks | The shrinking commissions that banks have made of their equity broker units may grow even smaller. Read More »

OpenFin is unveiling an app store for old-school Wall Street traders in a bid to become the iCloud of banking Dakin Campbell | OpenFin CEO Mazy Dar was this week named one of Business Insider's 10 people transforming finance. Read More »

The research chief at the world's largest hedge fund unpacks a market that's suddenly opening up to US investors — and why the gold rush is a once-in-a-lifetime opportunity Akin Oyedele | "You're not going to get a lot of opportunities where such a large market opens up," Bridgewater's Karen Karniol-Tambour said. Read More »

The lawyer who led Canopy Growth's groundbreaking $3.4 billion purchase of US marijuana cultivator Acreage Holdings says it will 'untap the market' for companies hunting similar deals Jeremy Berke | The deal sent a shockwave through the cannabis industry and may pave the way for big consumer and pharma companies to get in on the US cannabis craze. Read More »

GOLDMAN SACHS: A trade crucial for stock-market survival is the cheapest it's been since before the financial crisis. Here's how you can get involved. Joe Ciolli | Stocks may seem calm right now as they approach their record high, but that's exactly the time traders should be seeking hedges at discount prices. Read More »

This top-ranked wealth manager for the ultrarich rarely trades stocks, even when the market is in turmoil. Here's why. Marley Jay | The acclaimed wealth manager Brian Pfeifler of Morgan Stanley tells what young investors can learn from his choice to rarely trade the stocks he buys. Read More »

Why Wall Street is worried that Apple is getting left behind in the 5G arms race Charlie Wood | Many industry analysts predict a tough time for Apple in the race to embrace 5G wireless, but this won't necessarily harm the company long term. Read More »

A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease Erin Brodwin | Insitro and Gilead are teaming up to create drugs for a liver disease affecting millions. The startup is backed by Jeff Bezos and Andreessen Horowitz. Read More »

The JPMorgan, Amazon, and Berkshire Hathaway healthcare venture is setting up shop in NYC to snag top tech workers Lydia Ramsey | The new company is opening a New York office near Union Square in Manhattan and plans to hire for technology and engineering roles. Read More »

'Vulnerable to catastrophe': One market bear explains why stocks will crash 30% by the end of 2019 — and then flatline for the next 12 years Joe Ciolli | The renowned market bear John Hussman lays out why he thinks the S&P 500 is in for a tough, money-losing road ahead. Read More »

Share This Email    Read Business Insider On The Go

Email sent to: ipat39@gmail.com Manage your email preferences   |   Unsubscribe Terms of Service   |   Privacy Policy Business Insider. 150 Fifth Ave, New York, NY 10011